| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -40% |
| 3Y CAGR | -20% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -96% |
| 3Y CAGR | +28% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,627.00 -0.60 (0.01%) | 21,168.16 | 28.79 | 5.04 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,817.60 +97.10 (3.57%) | 20,634.90 | 30.43 | 5.75 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,901.00 +33.00 (0.48%) | 17,175.63 | 101.26 | 19.68 | ||
Natco PharmaNATCOPHARM | ₹838.80 -4.45 (0.53%) | 15,100.75 | 13.19 | 1.64 |